| Naslov: | The male hormone reset : how GLP-1RAs, lifestyle and testosterone transform obesity-linked problems |
|---|
| Avtorji: | ID Groti Antonič, Kristina (Avtor)
ID Zitzmann, Michael (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (1,10 MB)
MD5: F9A257B13DC204912B4CAB5008349539
 URL - Izvorni URL, za dostop obiščite https://www.tandfonline.com/doi/full/10.1080/13685538.2025.2601423
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Introduction: Functional hypogonadism, a manifestation of testosterone deficiency in simultaneously present comorbidities, profoundly impairs quality of life in men with overweight and obesity - yet remains persistently under-recognized in clinical practice. Findings: Lifestyle modification constitutes first-line therapy, while pharmacological and surgical interventions increasingly complement it. Both promote substantial weight loss and may reverse obesity-related hypogonadism; bariatric surgery, in particular, elicits marked rises in circulating testosterone but entails risks of bone demineralization and uncertain long-term reproductive sequelae. Notwithstanding, testosterone deficiency itself represents a key driver of secondary osteoporosis, insulin resistance, anemia, fatigue, and depression as well as sexual symptoms. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have redefined obesity therapy through profound weight reduction and cardiometabolic benefit, yet concomitant losses of lean mass raise concern over sarcopenia and skeletal fragility. Conclusion: This focused review article aims to present a comprehensive update on the latest data concerning combining testosterone therapy with contemporary anti-obesity pharmacotherapy as a new standard of care for obese men with functional hypogonadism, uniting metabolic, vascular, sexual, cognitive, and skeletal benefits within a comprehensive strategy to fortify corporeal resilience and enhance quality of life. |
|---|
| Ključne besede: | male hypogonadism, testosterone, GLP-1RAs, obesity, bones, osteoporosis |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2025 |
|---|
| Št. strani: | str. 1-21 |
|---|
| Številčenje: | Vol. 28, no. 1, [article no.] 2601423 |
|---|
| PID: | 20.500.12556/DiRROS-24874  |
|---|
| UDK: | 616.4 |
|---|
| ISSN pri članku: | 1473-0790 |
|---|
| DOI: | 10.1080/13685538.2025.2601423 |
|---|
| COBISS.SI-ID: | 262655235 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 23. 12. 2025;
|
|---|
| Datum objave v DiRROS: | 23.12.2025 |
|---|
| Število ogledov: | 5 |
|---|
| Število prenosov: | 4 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
